Differences between MS patient characteristics in clinical trials and real populations

Stephen Krieger, physician: We are here at the ECTRIMS conference [European Committee for Treatment and Research in Multiple Sclerosis] in Amsterdam, the Netherlands, in the fall of 2022. It’s nice to be at a personal event. A lot of new work is presented here. A piece of work from Dr Ruth Dobson and colleagues on … Read more